CANCER-EMBRYONIC ANTIGEN IN PREDICTING THERAPEUTIC TUMOR PATHOMORPHISM AFTER NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH RECTAL CANCER

CANCER-EMBRYONIC ANTIGEN IN PREDICTING THERAPEUTIC TUMOR PATHOMORPHISM AFTER NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH RECTAL CANCER

The purpose of the study was to evaluate the prognostic significance of carcinoerembryonic antigen in patients with rectal cancer and correlate its baseline with the degree of therapeutic pathomorphosis after neoadjuvant chemoradiotherapy.Materials and methods. An estimate of the informative value o...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. V. Erygin, N. G. Minaeva, S. A. Ivanov, N. Yu. Dvinskikh, N. Yu. Novikov, B. A. Berdov, A. A. Nevolskikh, A. A. Karpov, Yu. Yu. Mikhalev, I. A. Evtekhov, L. O. Petrov
Format:	Article
Language:	Russian
Published:	QUASAR, LLC 2018-06-01
Series:	Исследования и практика в медицине
Subjects:	rectal cancer carcinoerembryonic antigen chemoradiotherapy therapeutic pathomorphosis
Online Access:	https://www.rpmj.ru/rpmj/article/view/265
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Carcinoembryonic antigen BEFORE AND AFTER neoadjuvant chemoradiotherapy IN PREDICTION OF pathological complete response in patients with locally advanced rectal cancer
by: N. V. Severskaya, et al.
Published: (2018-11-01)

Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01)

Spleen-preserving D2 subtotal distal resection of the stomach and corpocaudal resection of the pancreas after neoadjuvant induction chemotherapy and chemoradiotherapy: case report and literature review
by: V. Yu. Skoropad, et al.
Published: (2022-11-01)

Effect of immunoadjuvants on the disease course in patients with operable breast cancer
by: M. M. Vasilyeva, et al.
Published: (2019-02-01)

The role of chemoradiotherapy in the treatment of neuroendocrine rectal cancer: case reports
by: S. S. Gordeev, et al.
Published: (2022-09-01)

Management strategy for rectal cancer patients with complete clinical response after chemoradiotherapy
by: A. A. Medvednikov, et al.
Published: (2025-03-01)

Morphological evaluation of rentgenendovaskular interventions for cervical cancer
by: A. V. Vazhenin, et al.
Published: (2014-07-01)

Response Assessment after Neoadjuvant Chemoradiotherapy in Rectal Cancer
by: Anuradha Chandramohan, et al.
Published: (2025-05-01)

Surgical tactics for esophageal cancer with complete pathomorphosis after chemoradiotherapy
by: B. V. Sigua, et al.
Published: (2024-10-01)

Peculiarities of the distribution and expression dynamics of apoptosis marker Bax in patients with rectal cancer under the influence of neoadjuvant chemoradiotherapy with the usage of nitric oxide precursor
by: V. V. Golotyuk
Published: (2015-08-01)

Erythropoietins (Epostim®) during chemoradiotherapy for malignancies in anemic patients
by: V. A. Titova, et al.
Published: (2014-08-01)

CHEMORADIOTHERAPY FOR ORAL CANCER USING HYPERFRACTIONATED RADIATION SCHEDULE
by: M. U. Radzhapova, et al.
Published: (2021-05-01)

Pathomorphosis of stage IIB cervical cancer in preoperative radiation therapy
by: A.E. Kryzhanivska, et al.
Published: (2013-08-01)

Long‐Term Survival Analysis of Neoadjuvant Chemoradiotherapy Versus Adjuvant Chemoradiotherapy for Locally Advanced Low Rectal Cancer
by: Siyuan Chen, et al.
Published: (2025-08-01)

Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
by: V. A. Grigorenko, et al.
Published: (2021-07-01)

PATHOLOGICAL COMPLETE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2020-07-01)

Concurrent vs. sequential chemoradiotherapy: a survival boost for lung cancer patients
by: Jinbiao Xu, et al.
Published: (2025-05-01)

MRI IN THE ASSESSMENT OF TUMOR RESPONSE TO CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER
by: N. G. Trukhacheva, et al.
Published: (2016-02-01)

The Influence of Neoadjuvant Chemoradiotherapy on Muscle Mass in Patients with Rectal Cancer
by: Gregory Simpson, et al.
Published: (2019-07-01)

Metformin’s impact on tumor regression grade in diabetic patients with rectal cancer undergoing neoadjuvant chemoradiotherapy
by: Nai-Yu Lin, et al.
Published: (2025-07-01)

Alpha-fetoprotein-producing rectal cancer successfully responded to preoperative chemoradiotherapy: case report
by: Yuki Nakamura, et al.
Published: (2018-09-01)

Chemoradiotherapy effcacy in squamous cell rectal cancer: a propensity score matched analysis
by: V. V. Murzo, et al.
Published: (2023-09-01)

ANALYSIS OF HEMATOLOGIC, HEPATIC AND PANCREATIC TOXICITY DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2018-07-01)

Quality of life in patients with pan-cancer undergoing concurrent chemoradiotherapy: a bibliometric analysis (1995-2024)
by: Ao Shen, et al.
Published: (2025-08-01)

Direct effectiveness of adding local hyperthermia to the scheme of neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: S. A. Ivanov, et al.
Published: (2020-09-01)

Role of mast cell in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
by: Masaaki Nishi, et al.
Published: (2025-01-01)

A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer
by: Arunima Gupta, et al.
Published: (2014-01-01)

Immunomodulators in Maintenance Therapy of Tuberculosis With Its Patomorphosis Features Taken Into Consideration
by: V. M. Kolomiets, et al.
Published: (2020-05-01)

Pressurized intraperitoneal aerosolized chemotherapy clinical efficacy in the combined treatment of newly diagnosed ovarian cancer with peritoneal carcinomatosis and ascites
by: A. S. Dzasochov, et al.
Published: (2024-12-01)

Features of anorectal function after radiation therapy in patients with rectal cancer
by: O. I. Kit, et al.
Published: (2024-05-01)

ASSESSMENT OF HISTOPATHOLOGICAL RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN GASTRIC CANCER PATIENTS: A MULTI-CENTER RANDOMIZED STUDY
by: V. Yu. Skoropad, et al.
Published: (2020-10-01)

The effect of the relative dose intensity of chemoradiotherapy on the effectiveness of therapy of locally advanced unresectable non-small cell lung cancer
by: A. E. Glukhareva, et al.
Published: (2024-03-01)

Understanding and considerations of radiation-induced rectal and anal injury after neoadjuvant chemoradiotherapy for rectal cancer
by: Zhu Xiaoming, et al.
Published: (2023-10-01)

ANALYSIS OF SAFETY OF NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER (RESULTS OF A MULTICENTER RANDOMIZED TRIAL)
by: V. Yu. Skoropad, et al.
Published: (2020-09-01)

Clinical and morphological response to neoadjuvant chemotherapy followed by chemoradiotherapy in a patient with locally advanced gastric cancer: a case report
by: V. Yu. Skoropad, et al.
Published: (2023-06-01)

Gut microbiome signature in response to neoadjuvant chemoradiotherapy in patients with rectal cancer
by: Tingmei Duan, et al.
Published: (2025-04-01)

Short‐Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients
by: Rongxin Zhang, et al.
Published: (2025-08-01)

The Role of Pre-Treatment Inflammatory Biomarkers in Predicting Tumor Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
by: Yunus Emre Altıntaş, et al.
Published: (2025-05-01)

Risk factors of pathologic complete response for neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Liangjing Zhou, et al.
Published: (2025-07-01)

Comprehensive malnutritional index for predicting clinical outcomes in locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy
by: Yu Xu, et al.
Published: (2024-10-01)